The global biopharmaceutical third party logistics market size is expected to be worth around US$ 150.2 billion by 2030, according to a new report by Vision Research Reports.
The global biopharmaceutical third party logistics market size was valued at US$ 96.4 billion in 2020 and is anticipated to grow at a CAGR of 6.6% during forecast period 2021 to 2030.
|Market Size||US$ 150.2 Bn by 2030|
|Growth Rate||CAGR of 6.6% From 2021 to 2030|
|Forecast Period||2021 to 2030|
|Segments Covered||Supply chain, service type|
|Regional Scope||North America, Europe, Asia Pacific, Latin America, Middle East & Africa|
|Companies Mentioned||DHL International GmbH.; SF Express; United Parcel Service of America, Inc.; AmerisourceBergen Corporation; DB Schenker; Kuehne and Nagel; Kerry logistics network limited; Agility|
The rising trend of outsourcing logistics, the focus of pharmaceutical players on their distribution network owing to its strong sales numbers, and the rise in the number of biosimilar launches are some of the key factors driving the market.
hese advanced vehicles are designed to automate and provide temperature control systems during transportation that help in reducing complexities, human error, and damage to products in transit. Thus, these monitoring solutions allow visibility that can converse breaches through automatic alerts by providing information to execute contingency plans.
By Supply Chain Analysis
the non-cold chain logistics segment dominated the market for biopharmaceutical third-party logistics (3PL) and contributed to the largest revenue share of 80.8%. This is owing to an increase in pharmaceutical sales through distributors. 3PL services provide greater scalability, higher visibility, reduce overall operating costs, and help develop a stronger logistics network with higher returns and lower risks.
The cold chain is projected to be the fastest-growing supply chain segment with a CAGR of 9.6% in the market for biopharmaceutical third-party logistics (3PL) over the forecast period. This is majorly owing to the rising demand for a new class of drugs, called biologics that have shown tremendous growth over the past few years.
By Service Type Analysis
the warehousing and storage segment dominated the market for biopharmaceutical third-party logistics (3PL) and held the largest revenue share of 43.6%. This is attributed to a large demand for 3PL services from the pharmaceutical and healthcare industry.
The other segment is projected to expand at a lucrative CAGR of 6.4% in the market for biopharmaceutical third-party logistics (3PL) over the forecast period. Packaging, custom and duty management, procurement services, and a few other values added services are included in this segment.
By Regional Analysis
North America dominated the biopharmaceutical third-party logistics (3PL) market and accounted for the largest revenue share of 41.5% in 2020. This is majorly attributed to the dominance of the region in the biologics and pharmaceutical drugs market and an increase in exports and imports for biopharmaceuticals.
In Asia Pacific, the market for biopharmaceutical third-party logistics (3PL) witnessed the second largest revenue of USD 15.4 billion in 2020 and is also expected to witness the fastest CAGR of 7.2% over the forecast period.
DHL International GmbH
United Parcel Service of America, Inc.
KUEHNE + NAGEL
Kerry Logistics Network Limited
By Service Type
Warehousing and Storage
Middle East & Africa
The Biopharmaceutical Third Party Logistics market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Biopharmaceutical Third Party Logistics market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Biopharmaceutical Third Party Logistics market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biopharmaceutical Third Party Logistics market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Biopharmaceutical Third Party Logistics market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Biopharmaceutical Third Party Logistics capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Biopharmaceutical Third Party Logistics by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Biopharmaceutical Third Party Logistics market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Biopharmaceutical Third Party Logistics market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Biopharmaceutical Third Party Logistics market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Biopharmaceutical Third Party Logistics industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Biopharmaceutical Third Party Logistics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Biopharmaceutical Third Party Logistics market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Biopharmaceutical Third Party Logistics market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Biopharmaceutical Third Party Logistics market. These factors have benefited the growth of the global market for Biopharmaceutical Third Party Logistics. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Biopharmaceutical Third Party Logistics. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Biopharmaceutical Third Party Logistics are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
The study objectives of this report are:
Healthcare ERP Market (By Function: Inventory and Material Management, Supply Chain and Logistics Management, Patient Relationship Management, Finance and Billing; By Deployment: On-premises, Cloud) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Biotechnology & Pharmaceutical Services Outsourcing Market (By Service: Consulting, Auditing and Assessment, Regulatory Affairs, Product Maintenance, Product Design & Development, Product Testing & Validation, Training & Education; By End-use: Pharma, Biotech) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Endoscopy Operative Devices Market (By Product: Energy Systems, Access Devices, Suction & Irrigation Systems, Hand Instruments, Wound Retractors, Snares; By Application: Gastrointestinal (GI) Endoscopy, Laparoscopy, Obstetrics/ Gynecology Endoscopy, Arthroscopy, Urology Endoscopy (Cystoscopy), Bronchoscopy, Mediastinoscopy, Otoscopy, Laryngoscopy) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Weight Loss Supplements Market (By Type: Liquid, Powder, Softgels, Pills; By Ingredient: Vitamins & Minerals, Amino Acids, Natural Extracts/ Botanicals; By End-user: Under 18 years, 18 to 40 years, 40 to 50 years, Above 50 years; By Distribution Channel: Offline Channel, Online Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Healthcare ERP Consulting Services Market (By Functionality: Implementation, Training & Education; By End-Use: Life Science Companies, Healthcare Providers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...